US Broker Ratings

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 10.95% Upside in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a prominent player in the medical devices industry, has positioned itself as an intriguing investment opportunity within the healthcare sector. Headquartered in..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Exploring a 5.12% Dividend Yield Amidst Mixed Financial Signals

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a heavyweight in the dental equipment and healthcare consumables sector, presents a compelling case for investors who balance risk with income..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A 15.6% Upside Beckons as CNS Innovations Propel Growth

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a notable player in the biotechnology sector, is capturing investor attention with its robust pipeline of treatments targeting central nervous system..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A 22.76% Upside Potential Beckons Investors

iRhythm Technologies, Inc. (NASDAQ: IRTC), a leader in digital healthcare innovations, is making waves in the medical devices industry with its cutting-edge cardiac monitoring solutions. Known..

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating Through Challenges Amidst a Promising Biotech Future

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector, focusing on pioneering treatments for rare genetic diseases. With a market capitalization of..

ADMA Biologics Inc (ADMA) Investor Outlook: Exploring a 42.99% Potential Upside in Biotech

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its robust potential upside of 42.99%...

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 21.55% Upside Potential in the Competitive OTC Market

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the over-the-counter (OTC) health and personal care products sector, presents an intriguing opportunity for investors, with..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Growth in the Healthcare Sector

For investors with a keen eye on the healthcare sector, Bausch + Lomb Corporation (NYSE: BLCO) presents an intriguing opportunity. With a market capitalization of $6.1..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Gem with 38% Potential Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising advancements in treating rare neuroendocrine disorders. As a commercial-stage biopharmaceutical company..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Potential Upside of 164% Captures Investor Attention

Investors eyeing the biotechnology sector should keep a close watch on Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company with promising prospects. As the company focuses..

Oscar Health, Inc. (OSCR) Investor Outlook: Analyzing a 23.2% Revenue Growth in Healthcare Plans

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans sector, has emerged as an intriguing option for investors navigating the intricate landscape of..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Look at Its 121.74% Potential Upside

Vaxcyte, Inc. (PCVX), a company at the forefront of vaccine innovation, is capturing investor attention with its ambitious pipeline and significant stock potential. With a market..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with 41% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing investor attention with its strong growth trajectory and potential upside. Specializing in muscle..

RadNet, Inc. (RDNT) Stock Analysis: Uncovering a 17% Upside Potential for Investors

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, offers a compelling investment opportunity with a projected upside of 17.33%. As a leader in..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring the 3.32% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is captivating investors’ attention with its focus on developing innovative oncology treatments. With a market..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Healthcare Giant with a Strong 73.7% Return on Equity

Investors eyeing Medpace Holdings, Inc. (NASDAQ: MEDP) will find a healthcare powerhouse with impressive performance metrics and a robust market presence. Based in Cincinnati, Ohio, Medpace..

Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Potential with 38.5% Revenue Growth and Robust Analyst Support

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, is capturing the attention of investors with its compelling growth narrative and strong buy ratings from..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Navigating a Promising 4.05% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a biotechnology company with a market capitalization of $7.58 billion, is making waves in the healthcare sector with its innovative genetic..

Fresenius Medical Care AG (FMS) Stock Analysis: Discovering a Potential 22.72% Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, specializes in providing dialysis services and related products for patients with renal diseases...

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating the Biotech’s 3.39% Potential Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO), a burgeoning player in the biotechnology sector, is attracting attention with its innovative approach to tackling serious metabolic diseases. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds